[Ip-health] patents: squelching innovation

George Carter fiar at verizon.net
Wed Feb 6 03:50:31 PST 2013


Could not be more true. Cures and new antibiotics to address multi-drug resistant infections are sidelined for greed. Look at Gilead's refusal to pursue studies with a BMS drug as a perfect example.

This hegemony of evil, this economic genocide must end.
George M. Carter

More information about the Ip-health mailing list